InflaRx N.V.

Healthcare · Biotechnology

1.72$ +0.6% vs. previous close Closing price · As of: Oct 2, 2026

Statements

Balance Sheet

InflaRx N.V. (IFRX) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 167 million EUR. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Amounts Change % Common size %

Last 12 Full history

Download as CSV

All figures in millions of EUR.

Tick rows to compare them in a chart (up to 4)

Balance Sheet IFRX
Line item	Q3 16	Q4 16	Q1 17	Q2 17	Q3 17	Q4 17	Q1 18	Q2 18	Q3 18	Q4 18	Q1 19	Q2 19	Q3 19	Q4 19	Q1 20	Q2 20	Q3 20	Q4 20	Q1 21	Q2 21	Q3 21	Q4 21	Q1 22	Q2 22	Q3 22	Q4 22	Q1 23	Q2 23	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26
Total Assets	–	30	–	27	24	124	116	166	165	159	155	145	142	122	114	104	101	88	147	135	129	125	115	115	111	102	86	133	129	120	107	93	80	76	87	73	65	55	49	167
Current Assets	–	29	29	26	24	124	116	165	112	158	153	143	139	119	111	102	99	86	145	132	100	96	104	112	109	97	76	112	128	109	103	91	74	72	86	66	63	54	47	165
Cash	–	29	-29	25	22	123	115	156	56	55	47	54	27	33	21	36	45	26	79	72	70	26	40	15	18	16	2.1	20	22	13	25	19	26	18	47	13	6.4	16	15	147
Cash & Short-Term Investments	–	29	29	25	22	123	115	164	111	157	151	139	136	115	108	99	95	81	138	127	94	26	90	100	24	17	68	102	23	13	25	19	26	18	66	48	45	46	40	158
Receivables	–	0.2	–	–	–	0.1	0.2	0.0	0.0	0.0	1.1	1.1	0.9	–	1.1	1.2	1.2	1.4	1.4	0.9	0.9	1.3	1.5	1.5	1.6	1.4	2.1	2.9	3.4	3.8	0.0	0.0	0.1	1.7	1.7	1.8	–	1.4	1.7	1.6
Inventory	–	0.0	–	–	–	0.5	0.4	0.0	0.0	0.0	2.5	2.5	1.2	1.0	2.0	1.6	2.5	3.6	–	5.4	5.4	13	13	10	7.6	6.0	6.0	0.6	1.6	11	11	9.6	9.7	6.9	6.9	5.0	5.1	0.0	–	–
Property, Plant & Equipment	–	0.1	–	0.2	0.2	0.2	0.3	0.6	0.7	0.6	1.4	1.6	1.6	1.4	1.3	1.2	1.1	1.0	0.8	1.9	1.8	1.7	1.6	1.7	1.6	–	1.5	1.4	1.4	–	–	–	–	–	–	–	–	–	–	–
Goodwill	–	–	–	–	–	–	0.0	0.0	0.0	0.0	0.0	0.0	0.0	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–
Intangible Assets	–	0.0	–	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.5	0.5	0.5	0.4	0.4	0.4	0.4	0.3	0.3	0.3	0.2	0.2	0.2	0.2	0.1	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1
Total Liabilities	–	55	–	59	60	4.8	4.2	3.8	6.1	7.8	9.0	14	18	14	12	13	12	10	8.4	11	14	20	20	13	12	14	7.7	8.3	11	18	12	11	14	15	17	16	20	14	12	21
Current Liabilities	–	1.7	–	2.6	2.7	4.8	4.2	3.8	6.0	7.8	8.5	13	18	14	12	13	11	10	8.2	10	13	19	19	11	11	13	6.8	7.5	11	17	12	10	14	14	16	16	19	13	11	20
Short-Term Debt	–	53	53	57	57	0.3	0.0	0.0	0.0	0.2	0.2	0.3	0.3	0.5	0.5	0.5	0.5	0.3	0.3	0.4	0.4	0.4	0.4	0.4	0.4	0.4	0.4	0.4	0.4	0.4	0.4	0.4	0.4	0.4	0.4	0.4	0.3	0.3	0.3	0.3
Accounts Payable	–	1.5	–	2.5	2.5	4.5	3.1	2.2	1.4	6.7	7.0	12	17	12	10	11	10.0	1.7	7.1	8.9	12	1.7	9.5	7.9	7.4	1.6	4.6	5.2	6.0	5.1	7.6	8.5	12	3.4	8.4	9.7	9.2	5.4	0.4	5.3
Long-Term Debt	–	56	–	65	68	–	0.0	0.0	0.0	0.0	1.4	0.0	0.0	–	0.0	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–
Shareholders' Equity	–	-26	-26	-33	-36	119	112	162	159	151	146	131	123	107	102	91	90	78	139	124	115	105	95	102	99	88	79	125	118	103	95	82	65	61	70	57	45	42	37	146
Retained Earnings	–	-27	–	-36	-40	-51	-62	-64	-71	-81	-91	-106	-121	-134	-143	-153	-159	-168	-174	-189	-201	-214	-228	-228	-235	-243	-255	-263	-270	-286	-296	-310	-327	-332	-341	-355	-367	-378	-384	-394
Shares Outstanding	23	23	23	23	23	23	24	25	26	26	26	26	26	26	26	26	28	26	34	44	44	42	44	44	44	44	45	57	59	59	59	59	59	59	63	68	68	67	72	118

Showing the most recent 40 periods — older statements are on file for this stock.

Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?

Balance Sheet

Cookie settings